Sort
15,273 grants matching “antimicrobial resistance”
Selenocyanate as a novel treatment of cystic fibrosis lung disease
$398,011Brian J Day · National Jewish Health · R01 · FY2021 · HL
Dealing with Antibiotic Resistance: Antisense Technology
$397,987Marcelo E Tolmasky · California State University Fullerton · R15 · FY2013 · AI
ADHESIN-BASED NANOTHERAPEUTICS IN URINARY TRACT INFECTION
$397,963David Alan Hunstad · Washington University · R01 · FY2010 · DK
Targeting M. catarrhalis for Prevention and Treatment of Otitis Media
$397,961Anthony A Campagnari · State University Of New York At Buffalo · R01 · FY2020 · DC
Targeting M. catarrhalis for Prevention and Treatment of Otitis Media
$397,961Anthony A Campagnari · State University Of New York At Buffalo · R01 · FY2019 · DC
Targeting M. catarrhalis for Prevention and Treatment of Otitis Media
$397,961Anthony A Campagnari · State University Of New York At Buffalo · R01 · FY2017 · DC
Mechanism of the Usher in Assembly and Secretion of Pili
$397,915David G Thanassi · State University New York Stony Brook · R01 · FY2014 · GM
Selenocyanate as a novel treatment of cystic fibrosis lung disease
$397,875Brian J Day · National Jewish Health · R01 · FY2022 · HL
Analysis of interacellular host defenses in Salmonella pathogenesis
$397,842Andres Vazquez-Torres · University Of Colorado Denver · R01 · FY2010 · AI
Crosslinked Nanosponges for the Topical Treatment of Wound Biofilms
$397,710Vincent M. Rotello · University Of Massachusetts Amherst · R01 · FY2019 · AI
Aminoglycosides with reduced ototoxicity via miRNA targeting
$397,674Dev Priya Arya · Nubad, Llc · R41 · FY2020 · AI
Candidacidal Mechanisms of Salivary Histatins
$397,648Mira Edgerton · State University Of New York At Buffalo · R01 · FY2015 · DE
Bacterial RNAP sigma factor structure and function
$397,529Seth A Darst · Rockefeller University · R01 · FY2011 · GM
Regulating Cathelicidin Expression for Disease Therapy
$397,500Adrian Friedrich Gombart · Cedars-Sinai Medical Center · R01 · FY2007 · AI
Antioxidant-based mechanisms used by staphyloccocus aureus to evade host defenses
$397,500George Y Liu · Cedars-Sinai Medical Center · R01 · FY2007 · AI
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
$397,500Michael Shiloh · Ut Southwestern Medical Center · R01 · FY2016 · AI
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
$397,500Michael Shiloh · Ut Southwestern Medical Center · R01 · FY2015 · AI
TLR2 and the Tubercle Granuloma
$397,500Padmini Salgame · Rbhs-New Jersey Medical School · R01 · FY2015 · AI
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
$397,500Michael Shiloh · Ut Southwestern Medical Center · R01 · FY2012 · AI
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
$397,500Michael Shiloh · Ut Southwestern Medical Center · R01 · FY2014 · AI
TLR2 and the Tubercle Granuloma
$397,500Padmini Salgame · Rbhs-New Jersey Medical School · R01 · FY2014 · AI
Peptide-Based Quorum Sensing Controlling Virulence in Bacillus anthracis
$397,500Hyunwoo Lee · University Of Illinois At Chicago · R56 · FY2011 · AI
Quantifying Microbial Keratitis to Predict Outcomes: An Imaging and Epidemiologic Approach
$397,484Maria Anneke Woodward · University Of Michigan At Ann Arbor · R01 · FY2021 · EY
Metabolic Control of Persistence in Individual Bacteria
$397,290Guillaume Lambert · Cornell University · R35 · FY2021 · GM
Candidacidal Mechanisms of Salivary Histatins
$397,284Mira Edgerton · State University Of New York At Buffalo · R01 · FY2018 · DE